logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 인천지방법원 2020.01.17 2019가합58475
보험금
Text

1. All of the plaintiff's claims are dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

Reasons

1. Under Article 1 (Grounds for Payment of Insurance Money) of the Basic Facts, where the insured is diagnosed and confirmed as 20 major diseases as stipulated in Article 4 (Definition and Determination of Diagnosis) during the insurance period of this Special Terms and Conditions, and where the insured undergoes an operation for the purpose of direct treatment of such 20 major diseases, the following amount shall be paid to the beneficiary as 20 major disease surgery expenses per 10% of the total insurance amount per 100% of the total insurance amount per operation for not less than one year less than 1 year in classification (hereinafter “insurance Money”).

Article 2 (Detailed Provisions concerning Payment of Insurance Money) (2) Where a patient is diagnosed or treated in the past (referring to the period subject to notification of the relevant disease) due to a disease that falls under the "Duty to Notify before the contract (limited to important matters)" in the application form, insurance money related to the relevant disease shall not be paid out of insurance money under Article 1 (Grounds for Payment of Insurance Money). A.

On October 11, 2017, the Plaintiff entered into an insurance contract in the attached list (hereinafter “instant insurance contract”) with Defendant, the insured, and the beneficiary of survival, who is an insurance company, as the Plaintiff. From October 11, 2017 to October 11, 207, the insurance period was from October 11, 2017 to which the insurance period was set up, and not more than the special terms and conditions for “20 major disease surgery expenses II (the insurance amount was KRW 3,00,000)” among the said insurance contract.

The contents of this chapter are as follows:

나. 원고는 이 사건 보험계약 체결일인 2017. 10. 11.부터 5년 이내인 2014. 12. 15.경부터 2015. 10. 26.경까지 인천 소재 C안과에서 아래와 같이 양측 녹내장 진단으로 11회에 걸쳐 통원치료 및 녹내장 치료제인 점안액 엘라좁점안현탁액과 코솝점안액 등의 투약 처방을 받았고, 이에 따라 위 점안액을 30일 이상 연속하여 투약하였다.

The examination and treatment of the first day of 2014-12-15 of the Act, the suspicion of the first day of 12014-12-15 of the Act, the second day treatment, the second day treatment, the EL narrow point deposit amount, the second day 22014-12-22 of the draft of algorily Luxembourg, both suspicions of the last day of 32015-01-05.

arrow